Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994

Gynecologic Oncology

Volumn 77, Issue 2, 2000, Pages 248-253

  Craighead, Peter S ^a   Sait, Khalid ^a   Stuart, Gavin C ^a   Arthur, Keith ^a   Nation, Jill ^a   Duggan, Maire ^b   Guo, Dianlin ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adjuvant radiotherapy; Endometrial carcinoma; Uterine serous papillary carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT OUTCOME;

EID: 0034027223     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5746     Document Type: Article

References (18)

1. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 6:1982;93-108.
2. Goff B A, Kato D, Schmidt R A, Ek M, Ferry J. Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol. 54:1994;264-267.
3. Dunton C, Gulnar G, McFarland M, Hernandez E. Uterine papillary serous carcinoma: a review. Obstet Gynecol Surv. 46:1991;97-102.
4. Nicklin J, Copeland L. Endometrial papillary serous carcinoma: patterns of spread and treatment. Clin Obstet Gynecol. 39:1996;680-695.
5. Sutton G, Brill L, Michael H, Stehman F, Ehrlich C. Malignant papillary lesions of the endometrium. Gynecol Oncol. 27:1987;294-304.
6. Carcangui M, Chambers J. Uterine papillary serous carcinoma: a study of 108 cases with emphasis on the prognostic significance of associated endometrial carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol. 47:1992;298-305.
7. Carcangiu M, Chambers J. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinico pathological features and survival. Int J Gyn Pathol. 14:1995;30-38.
8. Gitsch G, Friedhandler M, Wain G V, Hacker N. Uterine papillary serous carinoma: a clinical study. Cancer. 75:May 1995;2239-2243.
9. Roberts, J, Brunetto, V, Keys, H, Zaino, R, Spiros, N, et al., A phase III randomized study of surgery vs surgery plus adjuvant radiotherapy in intermediate risk endometrial carcinoma (GOG 99), Abstract 35, Proceedings of the Society of Gynecol Oncologists, 1998.
10. Mallipeddi P, Kapp D, Teng N. Long term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer. 71:1993;3076-3081.
11. Parkash L, Carcangui M. Uterine papillary serous carcinoma and radiotherapy. Cancer. 69:1992;494-501.
12. Frank A, Tseng P, Haffty B, Papadopoulos D P, Kacinski B. Adjuvant whole abdominal radiation therapy in uterine papillary serous carcinoma. Cancer. 68:1991;1516-1519.
13. Grice J, Ek M, Greer B, Koh W J, Muntz H. Uterine papillary serous carcinoma: evaluation of long term survival in surgically staged patients. Gynecol Oncol. 69:1998;69-73.
14. Aquino Parsons C, Lim P, Wong F, Milenberger M. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO Stage Ia and Ib endometrial adenocarcinoma: treatment implications. Gynecol Oncol. 71:1998;83-86.
15. Christman E, Kapp D, Hendrickson M, Howes A, Ballon S. Therapeutic approaches to uterine papillary serous carcinoma: a preliminary report. Gynecol Oncol. 26:1987;228-235.
16. Levenback C, Burke T, Silva E, Morris M, Gershenson D. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin and cyclophosphamide (PAC). Gynecol Oncol. 46:1992;317-321.
17. Rosenberg P, Boeryd B, Simonsen E. A new aggressive approach to high grade endometrial cancer of possible benefit to Stage I uterine papillary cancer. Gynecol Oncol. 48:1993;32-37.
18. Price F, Chambers S, Carcangui M L, Kohorn E, Schwartz P. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 51:1993;383-389.